APH vs CDTX
Amphenol Corporation (APH) versus Cidara Therapeutics Inc (CDTX) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
APH currently screens at market cap $170.77B and trailing P/E 39.9. CDTX currently screens at market cap $6.96B.
Not investment advice. Open the APH and CDTX stock pages for the full models.
Not investment advice.